Nicotine improves obesity and hepatic steatosis and ER stress in diet-induced obese male rats

Endocrinology

Volumn 155, Issue 5, 2014, Pages 1679-1689

  Seoane Collazo, Patricia ^a,b   Martínez De Morentin, Pablo B ^a,b   Fernø, Johan ^a,c   Diéguez, Carlos ^a,b   Nogueiras, Rubén ^a,b   López, Miguel ^a,b  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; NICOTINE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; BROWN ADIPOSE TISSUE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; ENERGY; ENERGY BALANCE; ENZYME ACTIVATION; FATTY LIVER; FOOD INTAKE; HOMEOSTASIS; INFLAMMATION; INSULIN BLOOD LEVEL; LIPID DIET; LOW FAT DIET; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; THERMOGENESIS;

ADIPOSE TISSUE, BROWN; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; APPETITE DEPRESSANTS; APPETITE REGULATION; DIET, FAT-RESTRICTED; DIET, HIGH-FAT; DYSLIPIDEMIAS; ENDOPLASMIC RETICULUM STRESS; FATTY LIVER; HYPERINSULINISM; HYPOTHALAMUS; INJECTIONS, SUBCUTANEOUS; LIVER; MALE; NICOTINE; NICOTINIC AGONISTS; OBESITY; RATS; RATS, SPRAGUE-DAWLEY; THERMOGENESIS; WEIGHT LOSS;

EID: 84899442593     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-1839     Document Type: Article

References (62)

1. de Morentin PB, López M. "Mens sana in corpore sano": exercise and hypothalamic ER stress. PLoS Biol. 2010;8:e1000464.
2. Dietrich MO, Horvath TL. Limitations in anti-obesity drug development: the critical role of hunger-promoting neurons. Nat Rev Drug Discov. 2012;11:675-691.
3. André C, Cota D. Coupling nutrient sensing to metabolic homoeostasis: the role of the mammalian target of rapamycin complex 1 pathway. Proc Nutr Soc. 2012;71:502-510.
4. Lancha A, Frühbeck G, Gómez-Ambrosi J. Peripheral signalling involved in energy homeostasis control. Nutr Res Rev. 2012;25:223-248.
5. Malik VS, Willett WC, Hu FB. Global obesity: trends, risk factors and policy implications. Nat Rev Endocrinol. 2013;9:13-27.
6. Caro JF, Kolaczynski JW, Nyce MR, et al. Decreased cerebrospinalfluid/ serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet. 1996;348:159-161.
7. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive- leptin concentrations in normal-weight and obese humans. N Engl J Med. 1996;334:292-295.
8. López M, Tovar S, Vázquez MJ, et al. Perinatal overfeeding in rats results in increased levels of plasma leptin but unchanged cerebrospinal leptin in adulthood. Int J Obes (Lond). 2007;31:371-377.
9. Nogueiras R, Pérez-Tilve D, Veyrat-Durebex C, et al. Direct control of peripheral lipid deposition by CNS GLP-1 receptor signaling is mediated by the sympathetic nervous system and blunted in diet induced obesity. J Neurosci. 2009;29:5916-5925.
10. Finan B, Yang B, Ottaway N, et al. Targeted estrogen delivery reverses the metabolic syndrome. Nat Med. 2012;18:1847-1856.
11. Filozof C, Fernández Pinilla MC, Fernández-Cruz A. Smoking cessation and weight gain. Obes Rev. 2004;5:95-103.
12. Grunberg NE. A neurobiological basis for nicotine withdrawal. Proc Natl Acad Sci USA. 2007;104:17901-17902.
13. FrankishHM,Dryden S,WangQ, Bing C, MacFarlane IA, Williams G. Nicotine administration reduces neuropeptide Y and neuropeptide Y mRNA concentrations in the rat hypothalamus: NPY may mediate nicotine's effects on energy balance. Brain Res. 1995;694: 139-146.
14. Li MD, Parker SL, Kane JK. Regulation of feeding-associated peptides and receptors by nicotine. Mol Neurobiol. 2000;22:143-165.
15. Fornari A, Pedrazzi P, Lippi G, Picciotto MR, Zoli M, Zini I. Nicotine withdrawal increases body weight, neuropeptide Y and Agouti- related protein expression in the hypothalamus and decreases uncoupling protein-3 expression in the brown adipose tissue in highfat fed mice. Neurosci Lett. 2007;411:72-76.
16. Mineur YS, Abizaid A, Rao Y, et al. Nicotine decreases food intake through activation of POMC neurons. Science. 2011;332:1330-1332.
17. Martínez de Morentin PB, Whittle AJ, et al. Nicotine induces negative energy balance through hypothalamic AMP-activated protein kinase. Diabetes. 2012;61:807-817.
18. Tweed JO, Hsia SH, Lutfy K, Friedman TC. The endocrine effects of nicotine and cigarette smoke. Trends Endocrinol Metab. 2012; 23:334-342.
19. Yoshida T, Sakane N, Umekawa T, et al. Nicotine induces uncoupling protein 1 in white adipose tissue of obese mice. Int J Obes Relat Metab Disord. 1999;23:570-575.
20. Arai K, Kim K, Kaneko K, et al. Nicotine infusion alters leptin and uncoupling protein 1 mRNA expression in adipose tissues of rats. Am J Physiol Endocrinol Metab. 2001;280:E867-E876.
21. Li MD, Kane JK, Parker SL, McAllen K, Matta SG, Sharp BM. Nicotine administration enhances NPY expression in the rat hypothalamus. Brain Res. 2000;867:157-164.
22. Lage R, González CR, Diéguez C, López M. Nicotine treatment regulates neuropeptide S system expression in the rat brain. Neurotoxicology. 2007;28:1129-1135.
23. López M, Varela L, Vázquez MJ, et al. Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance. Nat Med. 2010;16:1001-1008.
24. Imbernon M, Beiroa D, Vázquez MJ, et al. Central melanin-concentrating hormone influences liver and adipose metabolism via specific hypothalamic nuclei and efferent autonomic/JNK1 pathways. Gastroenterology. 2013;144:636-649.
25. Whittle AJ, Carobbio S, Martins L, et al. Bmp8b increases brown adipose tissue thermogenesis through both central and peripheral actions. Cell. 2012;149:871-885.
26. Beiroa D, Romero-Pico A, Langa C, et al. Heterozygous deficiency of endoglin decreases insulin and hepatic triglyceride levels during high fat diet. PLoS One. 2013;8:e54591.
27. López M, Lage R, Saha AK, et al. Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin. Cell Metab. 2008; 7:389-399.
28. Varela L, Martínez-Sánchez N, Gallego R, et al. Hypothalamic mTORpathway mediates thyroid hormone-induced hyperphagia in hyperthyroidism. J Pathol. 2012;227:209-222.
29. Ramírez S, Martins L, Jacas J, et al. Hypothalamic ceramide levels regulated by CPT1C mediate the orexigenic effect of ghrelin. Diabetes. 2013;62:2329-2337.
30. Grunberg NE, Popp KA, Bowen DJ, Nespor SM, Winders SE, Eury SE. Effects of chronic nicotine administration on insulin, glucose, epinephrine, and norepinephrine. Life Sci. 1988;42:161-170.
31. Saah MI, Raygada M, Grunberg NE. Effects of nicotine on body weight and plasma insulin in female and male rats. Life Sci. 1994; 55:925-931.
32. Malhi H, Kaufman RJ. Endoplasmic reticulum stress in liver disease. J Hepatol. 2011;54:795-809.
33. Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol. 2011;29:415-445.
34. Cnop M, Foufelle F, Velloso LA. Endoplasmic reticulum stress, obesity and diabetes. Trends Mol Med. 2012;18:59-68.
35. Pagliassotti MJ. Endoplasmic reticulum stress in nonalcoholic fatty liver disease. Annu Rev Nutr. 2012;32:17-33.
36. Di Gregorio GB, Yao-Borengasser A, Rasouli N, et al. Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone. Diabetes. 2005; 54:2305-2313.
37. Liu Y, Dang H, Li D, Pang W, Hammock BD, Zhu Y. Inhibition of soluble epoxide hydrolase attenuates high-fat-diet-induced hepatic steatosis by reduced systemic inflammatory status in mice. PLoS One. 2012;7:e39165.
38. Hampl JS, Betts NM. Cigarette use during adolescence: effects on nutritional status. Nutr Rev. 1999;57:215-221.
39. Bize R, Willi C, Chiolero A, et al. Participation in a population-based physical activity programme as an aid for smoking cessation: a randomised trial. Tob Control. 2010;19:488-494.
40. Hur YN, Hong GH, Choi SH, Shin KH, Chun BG. High fat diet altered the mechanism of energy homeostasis induced by nicotine and withdrawal in C57BL/6 mice. Mol Cells. 2010;30:219-226.
41. Mano-Otagiri A, Iwasaki-Sekino A, Ohata H, Arai K, Shibasaki T. Nicotine suppresses energy storage through activation of sympathetic outflow to brown adipose tissue via corticotropin-releasing factor type 1 receptor. Neurosci Lett. 2009;455:26-29.
42. Cusin I, Rohner-Jeanrenaud F, Stricker-Krongrad A, Jeanrenaud B. The weight-reducing effect of an intracerebroventricular bolus injection of leptin in genetically obese fa/fa rats. Reduced sensitivity compared with lean animals. Diabetes. 1996;45:1446-1450.
43. Kim JY, Nolte LA, Hansen PA, et al. High-fat diet-induced muscle insulin resistance: relationship to visceral fat mass. Am J Physiol Regul Integr Comp Physiol. 2000;279:R2057-R2065.
44. Zhou G, Myers R, Li Y, et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest. 2001;108:1167-1174.
45. Foretz M, Ancellin N, Andreelli F, et al. Short-term overexpression of a constitutively active form of AMP-activated protein kinase in the liver leads to mild hypoglycemia and fatty liver. Diabetes. 2005; 54:1331-1339.
46. Sangiao-Alvarellos S, Vázquez MJ, Varela L, et al. Central ghrelin regulates peripheral lipid metabolism in a growth hormone-independent fashion. Endocrinology. 2009;150:4562-4574.
47. Li Y, Xu S, Mihaylova MM, et al. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab. 2011;13: 376-388.
48. Porteiro B, Díaz-Ruíz A, Martínez G, et al. Ghrelin requires p53 to stimulate lipid storage in fat and liver. Endocrinology. 2013;154: 3671-3679.
49. Wang D, Sul HS. Insulin stimulation of the fatty acid synthase promoter is mediated by the phosphatidylinositol 3-kinase pathway. Involvement of protein kinase B/Akt. J Biol Chem. 1998;273: 25420-25426.
50. OnoH, Shimano H, Katagiri H, et al. Hepatic Akt activation induces marked hypoglycemia, hepatomegaly, and hypertriglyceridemia with sterol regulatory element binding protein involvement. Diabetes. 2003;52:2905-2913.
51. Jamal Uddin M, Joe Y, Zheng M, et al. A functional link between heme oxygenase-1 and tristetraprolin in the anti-inflammatory effects of nicotine. Free Radic Biol Med. 2013;65:1331-1339.
52. Cao J, Dai DL, Yao L, et al. Saturated fatty acid induction of endoplasmic reticulum stress and apoptosis in human liver cells via the PERK/ATF4/CHOP signaling pathway. Mol Cell Biochem. 2012; 364:115-129.
53. Vidal-Puig A, Jimenez-Liñan M, Lowell BB, et al. Regulation of PPAR γ gene expression by nutrition and obesity in rodents. J Clin Invest. 1996;97:2553-2561.
54. Medina-Gomez G, Virtue S, Lelliott C, et al. The link between nutritional status and insulin sensitivity is dependent on the adipocytespecific peroxisome proliferator-activated receptor-γ2 isoform. Diabetes. 2005;54:1706-1716.
55. Medina-Gomez G, Gray SL, Yetukuri L, et al. PPAR γ 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism. PLoS Genet. 2007;3:e64.
56. Lowe CE, O'Rahilly S, Rochford JJ. Adipogenesis at a glance. J Cell Sci. 2011;124:2681-2686.
57. Han KL, Choi JS, Lee JY, et al. Therapeutic potential of peroxisome proliferators-activated receptor-α/γ dual agonist with alleviation of endoplasmic reticulum stress for the treatment of diabetes. Diabetes. 2008;57:737-745.
58. Lee YJ, Ko EH, Kim JE, et al. Nuclear receptor PPARγ-regulated monoacylglycerol O-acyltransferase 1 (MGAT1) expression is responsible for the lipid accumulation in diet-induced hepatic steatosis. Proc Natl Acad Sci USA. 2012;109:13656-13661.
59. Yamauchi T, Waki H,KamonJ, et al. Inhibition ofRXRandPPARγ ameliorates diet-induced obesity and type 2 diabetes. J Clin Invest. 2001;108:1001-1013.
60. Matsusue K, Haluzik M, Lambert G, et al. Liver-specific disruption ofPPARγ in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes. J Clin Invest. 2003;111:737-747.
61. Friedman TC, Sinha-Hikim I, Parveen M, et al. Additive effects of nicotine and high-fat diet on hepatic steatosis in male mice. Endocrinology. 2012;153:5809-5820.
62. López M, Alvarez CV, Nogueiras R, Diéguez C. Energy balance regulation by thyroid hormones at central level. Trends Mol Med. 2013;19:418-427.